Stocks/TSX-V/PAIN

Vector Science and Therapeutics Corp. (PAIN : TSX-V)

Common Stock

$2.00

CAD

-0.19 (-8.68%)

Last updated: 2026-07-14

PAIN

Vector Science and Therapeutics Corp.

Source:WealthAwesomeWealthAwesome
$0.38 (23.46%)
30 day period
$1.60$2.08$2.57Jun 2Jun 23Jul 14

Performance

1 Day

-8.68%

1 Week

-18.37%

1 Month

+4.71%

YTD

+312.37%

Key Statistics

Market Cap

$12.04M

52W High

$2.65

52W Low

$0.35

P/E Ratio

-

50 Day MA

$1.68

200 Day MA

$1.63

Beta

4.63

Dividend Yield

-

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
7/14/2026$2.15$2.17$1.93$2.00$2.00131,788
7/13/2026$2.27$2.32$2.11$2.19$2.19237,231
7/10/2026$2.35$2.35$2.23$2.32$2.32406,182
7/9/2026$2.35$2.36$2.30$2.35$2.35217,080
7/8/2026$2.42$2.42$2.21$2.34$2.34181,738
7/7/2026$2.35$2.48$2.25$2.45$2.45498,832
7/6/2026$2.46$2.46$2.33$2.40$2.4084,674
7/3/2026$2.57$2.57$2.43$2.43$2.4387,153
7/2/2026$2.45$2.62$2.44$2.57$2.57392,701
6/30/2026$2.30$2.45$2.20$2.45$2.45222,067

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on PAIN's historical volatility

HistoricalForecast68%95%
C$0.45C$1.70C$2.96C$4.21C$5.46C$6.71TodayApr 29Jun 5Jul 14Aug 26Oct 9Nov 21

30-Day Vol

83.9%

Annualized

90-Day Vol

108.9%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$2.39

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$2.12C$1.59C$2.84
60 trading daysC$2.25C$1.50C$3.39
90 trading daysC$2.39C$1.45C$3.95

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Vector Science and Therapeutics Corp.

Vector Science and Therapeutics Corp. develops and sells novel biomechanical devices and active localized drug-delivery platforms. The company offers products and services based on its Smart, Steered, and Sustained framework for site-directed interventions in musculoskeletal tissue regeneration. The company has a development and manufacturing agreement with MPP Group LLC to develop and manufacture pharmaceutical-grade peptides and drug delivery devices. The company is based in Mequon, Wisconsin.

Financials

Revenue (TTM)
$0
EBITDA
-
Profit Margin
0.00%
ROE (TTM)
-104.10%
EPS (Diluted)
-0.49
Book Value
0.09

Advertisement

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Common Questions About PAIN

Advertisement